Longwall Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6

- Investments
-
127
- Portfolio
-
26
- Exits
-
21

Longwall Ventures General Information
Description
Founded in 2011, Longwall Ventures is a venture capital firm headquartered in Oxford, United Kingdom. The firm seeks to invest in early-stage companies across healthcare, science and engineering sectors.
Contact Information
Website
www.longwallventures.com
Year Founded
2011
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Quad One
- Becquerel Avenue, Harwell
- Oxford OX11 0RA
- England, United Kingdom
+44 01235 000000
Longwall Ventures Investments (127)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Caristo Diagnostics | 04-Apr-2023 | Later Stage VC | 000.00 | Decision/Risk Analysis | Generating Revenue | 0000000 00000 00.0 |
0000000 00000000 | 01-Feb-2023 | 00000 00000 | 000 | Other Commercial Products | Generating Revenue | 00000 00000 |
00000000000 | 06-Apr-2022 | 00000 00000 | 00.000 | Discovery Tools (Healthcare) | Generating Revenue | 0000000 0000 00.0 |
000000000 | 02-Mar-2022 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | 00000 00000 |
00000 0000000 0000 | 02-Mar-2022 | 00000 00000 | 00.00 | Electrical Equipment | Generating Revenue | 0000000 000000000 00.0 |
000000 00000 00000 | 01-Mar-2022 | 00000 00000 | 00.000 | Aerospace and Defense | Generating Revenue | 00000 00000 |
00000000000 | 01-Feb-2022 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 0000000 00000 00.0 |
00000000 | 02-Dec-2021 | 00000 00000 | 000.00 | Therapeutic Devices | Product In Beta Test | 0000000 00000 00.0 |
Wayland Additive | 29-Nov-2021 | Early Stage VC | 00.000 | Other Commercial Products | Generating Revenue | 00000 00000 |
Closed Loop Medicine | 02-Nov-2021 | Early Stage VC | 000.00 | Drug Discovery | Generating Revenue | 0000000 0000 00.0 |
Longwall Ventures Exits (21)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Oxford HighQ | 01-Apr-2023 | Out of Business | |
00000000 | 16-Dec-2022 | 000000000000000000 | |
0000000 | 01-Nov-2022 | 0000000000: 000000 | |
00000 | 16-Nov-2021 | 000 00 00000000 | |
000000 00000000000 | 11-Nov-2021 | 000000000000000000 | 00000 |
000000000000 | 21-Jun-2021 | 0000000000 | |
00000000 | 01-Sep-2020 | 000 00 00000000 | |
000000000 (00000 0 | 05-Jul-2019 | 0000000000: 000000 | |
NTL Biologica | 17-Jan-2019 | Secondary Transaction - Private | |
Ibexis | 25-Sep-2018 | Out of Business |
Longwall Ventures Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Longwall Ventures Investments by Industry, Year, and Region
Longwall Ventures Team (7)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Jane Burgoyne | Partner & Chief Financial Officer | 0 | 0 | Oxford, United Kingdom | |
David Denny | Partner | 00 | 0 | 0 | Oxford, United Kingdom |
Matthew Frohn Ph.D | Partner | 00 | 0 | 0 | Oxford, United Kingdom |
Michael Penington Ph.D | Partner | 00 | 0 | 0 | Oxford, United Kingdom |
Helen Viner | Financial Controller | Oxford, United Kingdom |
Longwall Ventures Co-Investors (69)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
British Business Bank | 6 | 0 | 0 |
![]() |
![]() |
Oxford Investment Consultants | 0 | 0 | 0 |
![]() |
![]() |
BGF | 0 | 0 |
![]() |
![]() |
|
UK Innovation & Science Seed Fund | 0 | 0 |
![]() |
![]() |
|
Wren Capital | 0 | 0 |
![]() |
![]() |